C-erbB-2 expression and oestrogen receptor status before and after neoadjuvant chemotherapy for primary breast cancer
Burcombe, R.J.; Makris, A.; Richman, P.I.; Daley, F.; Noble, S.; Wilson, G.D.
European Journal of Cancer 36(Suppl 5): S106-S107
2000
ISSN/ISBN: 0959-8049 Accession: 034511224
PDF emailed within 1 workday: $29.90
Related References
Bottini, A.; Berruti, A.; Bersiga, A.; Brunelli, A.; Brizzi, M.P.; Marco, B.D.; Cirillo, F.; Bolsi, G.; Bertoli, G.; Alquati, P.; Dogliotti, L. 1996: Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours Anticancer Research 16(5b): 3105-3110Jones, R.L.; Salter, J.; A'Hern, R.; Nerurkar, A.; Parton, M.; Reis-Filho, J.S.; Smith, I.E.; Dowsett, M. 2010: Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer Breast Cancer Research and Treatment 119(2): 315-323
Ring, A.E.; Smith, I.E.; Ashley, S.; Fulford, L.G.; Lakhani, S.R. 2004: Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer British Journal of Cancer 91(12): 2012-2017
Heitz, F.; Kümmel, S.; Lederer, B.; Solbach, C.; Engels, K.; Ataseven, B.; Sinn, B.; Blohmer, J.U.; Denkert, C.; Barinoff, J.; Fisseler-Eckhoff, A.; Loibl, S. 2019: Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy Geburtshilfe und Frauenheilkunde 79(10): 1110-1117
Lo, S.S.; Wang, H.C.; Shyr, Y.M.; Lui, W.Y. 1994: Can the hormonal receptor status of primary breast cancer be altered by neoadjuvant chemotherapy? Journal of Surgical Oncology 57(2): 94-96
Burcombe, R.J.; Makris, A.; Richman, P.I.; Daley, F.; Noble, S.; Wilson, G.D. 2000: Persistence of c-erbB-2 overexpression after neoadjuvant chemotherapy for primary breast cancer British Journal of Cancer 83(Suppl 1): 37
Lee, S.H.; Chung, M.A.; Quddus, M.R.; Steinhoff, M.M.; Cady, B. 2003: The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer American Journal of Surgery 186(4): 348-350
Bottini, A.; Berruti, A.; Bersiga, A.; Brunelli, A.; Brizzi, M.P.; Dimarco, B.; Bolsi, G.; Bertoli, F.C.rillo G.; Alquati, P.; Dogliotti, L. 1997: Influence of estrogen receptor status on cytokinetic changes induced by neoadjuvant chemotherapy in primary breast cancer Tumor Biology 18(Suppl 1): 24
Kitagawa, D.; Saji, S.; Horiguchi, S.-I.; Satoh, Y.; Horiguchi, K.; Toi, M.; Funata, N.; Kuroi, K. 2010: Alternation of estrogen receptor and progesterone receptor expression in primary breast cancer patients treated with neoadjuvant chemotherapy Breast Journal 16(4): 435-436
Parinyanitikul, N.; Lei, X.; Chavez-MacGregor, M.; Liu, S.; Mittendorf, E.A.; Litton, J.K.; Woodward, W.; Zhang, A.H.; Hortobagyi, G.N.; Valero, V.; Meric-Bernstam, F.; Gonzalez-Angulo, A.M. 2015: Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes Clinical Breast Cancer 15(2): 153-160
Ellis, M.J.; Coop, A.; Singh, B.; Mauriac, L.; Llombert-Cussac, A.; Jänicke, F.; Miller, W.R.; Evans, D.B.; Dugan, M.; Brady, C.; Quebe-Fehling, E.; Borgs, M. 2001: Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase IIi randomized trial Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(18): 3808-3816
Ellis, M.J.; Coop, A.; Quebefehling, E.; Borgs, M.; Singh, B.; Mauriac, L.; Llombertcussac, A.; Janicke, F.; Miller, W.R.; Evans, D.B.; Dugan, M.; Brady, C. 2001: Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer : evidence from a phase III randomized trial Journal of Clinical Oncology 19(18): 3808-3816
Singh, S.; , 2019: Effect of Neoadjuvant ChemoTherapy on Hormone Receptor (Er, Pr) Status and Her-2/Neu Expression in Indian Breast Cancer Patients: a Prospective Study International Journal of Advanced Research 7(8): 1134-1144
Yoshihisa Umekita; Nobumasa Enokizono; Yoshiatsu Sagara; Kazumi Kuriwaki; Takashi Takasaki; Aichi Yoshida; Hiroki Yoshida 1992: Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-α) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status Virchows Archiv 420(4): 345-351
Umekita, Y.; Enokizono, N.; Sagara, Y.; Kuriwaki, K.; Takasaki, T.; Yoshida, A.; Yoshida, H. 1992: Immunohistochemical studies on oncogene products (EFG-R, c-erbB-2) and growth factors (EGF, TGF-α) in human breast cancer : their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status Virchows Archiv. A, Pathological Anatomy and Histopathology 420(4): 345-351
Kim, H.J.; Noh, W.C.; Lee, E.S.; Jung, Y.S.; Kim, L.S.; Han, W.; Nam, S.J.; Gong, G.-Y.; Kim, H.J.; Ahn, S.H. 2020: Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer Breast Cancer Research: Bcr 22(1): 54
Loibl, S.; Müller, B.M.; von Minckwitz, G.; Schwabe, M.; Roller, M.; Darb-Esfahani, S.; Ataseven, B.; du Bois, A.; Fissler-Eckhoff, A.; Gerber, B.; Kulmer, U.; Alles, J.-U.; Mehta, K.; Denkert, C. 2011: Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy Breast Cancer Research and Treatment 130(2): 477-487
Umekita, Y.; Enokizono, N.; Sagara, Y.; Kuriwaki, K.; Takasaki, T.; Yoshida, A.; Yoshida, H. 1992: Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status Virchows Archiv. A Pathological Anatomy and Histopathology 420(4): 345-351
Silva, L.Roberto.da.; Vargas, R.Flora.; Shinzato, Júlia.Yoriko.; Derchain, S.Françoise.Mauricette.; Ramalho, S.; Zeferino, L.Carlos. 2019: Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 41(12): 710-717
Heatley, M.; Maxwell, P.; Whiteside, C.; Toner, P.G. 1993: C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma Pathology Research and Practice 189(3): 261-266